Skip to main content
Nancy Madinger, MD, Infectious Disease, Aurora, CO

NancyEMadingerMD

Infectious Disease Aurora, CO

Associate Professor of Medicine, University Colorado

Dr. Madinger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Madinger's full profile

Already have an account?

  • Office

    12605 E 16th Ave
    Aurora, CO 80045
    Phone+1 720-848-0000

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Infectious Disease, 1988 - 1992
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Internal Medicine, 1987 - 1988
  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1984 - 1987
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1984

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1985 - Present
  • CO State Medical License
    CO State Medical License 1987 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Press Mentions

  • Facile Accelerated Specific Therapeutic (FAST) Platform Develops Antisense Therapies to Counter Multidrug-Resistant Bacteria
    Facile Accelerated Specific Therapeutic (FAST) Platform Develops Antisense Therapies to Counter Multidrug-Resistant BacteriaMarch 12th, 2021
  • Multiplexed Deactivated CRISPR-Cas9 Gene Expression Perturbations Deter Bacterial Adaptation by Inducing Negative Epistasis
    Multiplexed Deactivated CRISPR-Cas9 Gene Expression Perturbations Deter Bacterial Adaptation by Inducing Negative EpistasisSeptember 3rd, 2018